Ra Pharmaceuticals publicizes pricing of its initial public offering

Unable to view this mail? Please click here to view in browser

Growing Pharma market in Southeast Asia

Pharmacovigilance regulations

Late-phase clinical and commercial production

The Future of Generic Drugs

e-Newsletter

www.pharmafocusasia.com | Archives | Advertise

News

Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma

EpiPen rival plans return to U.S. market in first-half 2017

Horizon Pharma plc Completes Acquisition of Raptor Pharmaceutical Corp.

Press Releases

Ra Pharmaceuticals Announces Pricing of Initial Public Offering

Entasis Announces Initiation of Phase I Clinical Trial of ETX2514

Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Greece

Events

01 -02 Nov 2016
Digital Pathology Congress Middle East

03 -04 Nov 2016
Pathology Update 2016

03 -05 Nov 2016
12th Nanotechnology Products Expo 2016

08 -10 Nov 2016
Extractables and Leachables Europe 2016

Articles
Untapped Opportunities in Southeast Asia *Sue Lee* Technical Portfolio Manager, World Courier Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years. With a population of about 620 million and a total area of 4.5 million kilometres it contains the region’s well-recognised study destinations of Malaysia...
State of Pharmacovigilance *Giovanni Furlan* EU QPPV, Helsinn Birex Pharmaceuticals, Ireland In recent years there has been a proliferation of pharmacovigilance guidelines and regulations. Regulatory authorities have implemented different requirements, templates and regulations, and some of them have asked pharmaceutical companies...
Projects
Catalent Pharma Solutions Plans $34 Million Expansion Of Biologics Manufacturing Facility in Madison, Wisconsin Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, plans for a new $34 million extension to its state-of-the-art Madison, Wisconsin biologics manufacturing facility...
Reports
Glioblastoma Multiforme – Cancer Immunotherapies Dominate First-in-Class... The Future of Generic Drugs and Strategies for Commercial Success Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022...

Editorial Calender

Media Pack

e-Magazine| Subscribe | Unsubscribe

www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd.
Media Resource Centre,2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555